I31.80
Conditions
Interventions
Group 1: Retrospective analysis of patients who were treated for cardiac tamponade at Charité - Universitätsmedizin between 1st of January 2023 and 31st of December 2025.
Sponsors
Klinik für Anästhesiologie und Intensivmedizin | CBF | Charité - Universitätsmedizin Berln
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients treated at Charité - Universitätsmedizin for cardiac tamponade between 1st of January 2023 and 31st of December 2025 - Adults only, of all sexes - Patient data must be complete to allow analysis of the research question
Exclusion criteria
Exclusion criteria: - Patients with cardiac tamponade and incomplete data (e.g. laboratory results or imaging findings) that prevent determination of the underlying etiology of the tamponade - Patients with cardiac tamponade and incomplete documentation of therapy and mortality
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary endpoint of descriptive primary research question: - Etiology of cardiac tamponade: traumatic, iatrogenic, aortic dissection, ventricular rupture after myocardial infarction, infectious, malignant, autoimmune, metabolic/endocrinological, idiopathic, other | — |
Secondary
| Measure | Time frame |
|---|---|
| secondary endpoint of descriptive secondary research question: - definitive treatment modality: medical therapy (without invasive intervention), pericardiocentesis ± drainage, pericardial window, pericardiectomy secondary endpoints of the secondary hypothesis: - In-hospital mortality - 30-day mortality exposures/covariates: - etiology - treatment - age - sex - comorbidities | — |
Countries
Germany
Contacts
Public ContactLara Josephin Matthees
Deutsches Herzzentrum der Charité, Klinik für Herz-, Thorax- und Gefäßchirurgie
Outcome results
None listed